The American Society of Clinical Oncology (ASCO) Annual Gastrointestinal Cancer Symposium will be held virtually this year due to the ongoing COVID-19 pandemic and highlights the latest in the treatment and management of gastrointestinal malignancies.
View all videosASCO GI 2021
.@CancerAdvocacy .@AdvocateCollab .@CancerSurvSM Please see below & consider participating in this important study! https://twitter.com/mandichapman/status/1364255138517499905
Calling all #Cancer Patients! Help us improve care for #LGBTQ patients by sharing your experiences with #CancerCare. You do not have to be #LGBTQ to take the survey but we especially welcome LGBTQ respondents #CancerSurvivorship https://is.gd/QUIRKSPatientFA
This week @AarmstrongDuke & I, w/ our @DukeGUCancer team, published a paper that took 5 years of work, showing expression of immune checkpoints on circulating tumor cells (CTCs) from patients with #prostatecancer. 1/n
https://biomarkerres.biomedcentral.com/articles/10.1186/s40364-021-00267-y
VIDEO: SAPROCAN: saracatinib and docetaxel for mCRPC w/ Robert Jones of @UofGlasgow
👉http://ow.ly/1xJJ50DDSMm👈
@VJOncology @OncoAlert @ASCO #GU21 #UroSoMe #UroOnc #OncoAlert #Oncology #PCsm #ProstateCancer #TrialUpdate #ClinOnc #MedOnc #ASCOGU
This was a great program. The treatments are changing quickly. Recent data with adstiladrin (uromigos paper of the month Jan21) - also the neoadjuvant durvalumab NIAGRA study is recruiting well. Is adjuvant nivo just around the corner? https://twitter.com/urodocash/status/1364578189050224640
@Uroweb @MRoupret @amassonlecomte @tompowles1 Impressive effort by @Uroweb @UrowebESU to make these educational efforts available to a wide audience. For my part, thoroughly enjoyed chatting with the always provocative @MRoupret @tompowles1 @Uromigos
ASCO GI 2021
The American Society of Clinical Oncology (ASCO) Annual Gastrointestinal Cancer Symposium will be held virtually this year due to the ongoing COVID-19 pandemic and highlights the latest in the treatment and management of gastrointestinal malignancies.
View all videos.@CancerAdvocacy .@AdvocateCollab .@CancerSurvSM Please see below & consider participating in this important study! https://twitter.com/mandichapman/status/1364255138517499905
Calling all #Cancer Patients! Help us improve care for #LGBTQ patients by sharing your experiences with #CancerCare. You do not have to be #LGBTQ to take the survey but we especially welcome LGBTQ respondents #CancerSurvivorship https://is.gd/QUIRKSPatientFA
This week @AarmstrongDuke & I, w/ our @DukeGUCancer team, published a paper that took 5 years of work, showing expression of immune checkpoints on circulating tumor cells (CTCs) from patients with #prostatecancer. 1/n
https://biomarkerres.biomedcentral.com/articles/10.1186/s40364-021-00267-y
VIDEO: SAPROCAN: saracatinib and docetaxel for mCRPC w/ Robert Jones of @UofGlasgow
👉http://ow.ly/1xJJ50DDSMm👈
@VJOncology @OncoAlert @ASCO #GU21 #UroSoMe #UroOnc #OncoAlert #Oncology #PCsm #ProstateCancer #TrialUpdate #ClinOnc #MedOnc #ASCOGU
This was a great program. The treatments are changing quickly. Recent data with adstiladrin (uromigos paper of the month Jan21) - also the neoadjuvant durvalumab NIAGRA study is recruiting well. Is adjuvant nivo just around the corner? https://twitter.com/urodocash/status/1364578189050224640
@Uroweb @MRoupret @amassonlecomte @tompowles1 Impressive effort by @Uroweb @UrowebESU to make these educational efforts available to a wide audience. For my part, thoroughly enjoyed chatting with the always provocative @MRoupret @tompowles1 @Uromigos
